Figure 4: Distribution of institutions with many publications on the use of stem cells for treatment of type 2 diabetes. Note: (A) The top ten scientific research institutions with relevant publications extracted from the WanFang database. I–X indicate (I) Shanghai Jiao Tong University, (II) Peking Union Medical College, (III) Chinese Academy of Medical Sciences, (IV) Affiliated Hospital of Qingdao University School of Medicine, (V) Nanjing Drum Tower Hospital Affiliated to Medical College of Nanjing University, (VI) Fourth Hospital of Hebei Medical University/Hebei Cancer Hospital, (VII) Affiliated Hospital of Zunyi Medical University, (VIII) Third Affiliated Hospital of Sun Yat-sen University, (IX) Lanzhou General Hospital of Lanzhou Military Region, (X) Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology. (B) The top ten institutions with relevant publications included in the Web of Science database. I–X indicate (I) the University of California System, (II) Harvard University, (III) Institut National De La Sante Et De La Recherche Medicale Inserm, (IV) China PLA General Hospital, (V) Shanghai Jiao Tong University, (VI) University of California Los Angeles, (VII) Pennsylvania Commonwealth System of Higher Education PCSHE, (VIII) University of California San Francisco, (IX) University of Padua, and (X) Air Force Military Medical University of China.